Revolutionary FDA Approval Marks Medical Milestone
Startup Clairity has achieved a groundbreaking milestone in healthcare technology, securing FDA approval for the agency’s first artificial intelligence tool specifically designed to predict five-year breast cancer risk from…
Population-wide cancer screening programs in Germany have tapped support from South Korean medical imaging AI providers.KOSDAQ-listed Lunit recently signed a five-year partnership with private radiology network Starvision Service to deploy several medical imaging AI…
Continue Reading
Source Credit: freepik
What You Should Know:
– Artificial intelligence (AI) could play a crucial role in identifying breast cancers that develop between routine screening mammograms, potentially detecting them before they become more advanced and challenging…
Continue Reading
Study Reveals Safe Alternatives to Surgical Excision
Recent findings published in the American Journal of Roentgenology (AJR) suggest that imaging surveillance may be a safe alternative to surgical excision for certain architectural distortions (ADs) detected…
What You Should Know:
– GE HealthCare has unveiled Invenia™ Automated Breast Ultrasound (ABUS) Premium, a cutting-edge 3D ultrasound system designed to revolutionize breast cancer screening for women with dense breast tissue.
– The technology integrates…
Continue Reading
Study Confirms AI Boosts Cancer Detection Rates
Lunit’s groundbreaking research published in Nature Communications has validated the effectiveness of AI-powered mammography screening in real-world settings. This first-of-its-kind large-scale, multicenter prospective study demonstrated that AI assistance…
Revolutionary Findings in Breast Cancer Screening
A landmark clinical trial has revolutionized breast cancer screening by demonstrating the remarkable effectiveness of artificial intelligence in mammography. The Mammography Screening with Artificial Intelligence (MASAI) trial, published in…
Strategic Acquisition Enhances AI Capabilities
ScreenPoint Medical’s acquisition of Biomediq A/S on January 8, 2025, represents a milestone in AI-driven breast cancer detection. This strategic merger follows ten years of collaborative research, integrating Biomediq’s quantitative…
What You Should Know:
– ScreenPoint Medical, a provider of AI-powered breast cancer screening solutions, acquires Biomediq A/S, a research-based company specializing in quantitative imaging biomarkers. Financial details of the acquisition were not disclosed.
– ScreenPoint’s…
Continue Reading
In resource-constrained countries like India, mammography-based breast screening is challenging to implement. This state-wide study, funded by the Government of Punjab, evaluated the use of Thermalytix, a low-cost, radiation-free AI tool, for breast cancer…
Continue Reading
